BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17160352)

  • 1. Prolyl endopeptidases.
    Gass J; Khosla C
    Cell Mol Life Sci; 2007 Feb; 64(3):345-55. PubMed ID: 17160352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases.
    Xiao B; Zhang C; Song X; Wu M; Mao J; Yu R; Zheng Y
    Eur J Med Chem; 2020 Sep; 202():112499. PubMed ID: 32668378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and mechanistic analysis of two prolyl endopeptidases: role of interdomain dynamics in catalysis and specificity.
    Shan L; Mathews II; Khosla C
    Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3599-604. PubMed ID: 15738423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced-fit mechanism for prolyl endopeptidase.
    Li M; Chen C; Davies DR; Chiu TK
    J Biol Chem; 2010 Jul; 285(28):21487-95. PubMed ID: 20444688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.
    Alvarez-Sieiro P; Martin MC; Redruello B; Del Rio B; Ladero V; Palanski BA; Khosla C; Fernandez M; Alvarez MA
    Appl Microbiol Biotechnol; 2014 Aug; 98(15):6689-700. PubMed ID: 24752841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy.
    Gass J; Ehren J; Strohmeier G; Isaacs I; Khosla C
    Biotechnol Bioeng; 2005 Dec; 92(6):674-84. PubMed ID: 16136593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure and molecular dynamics of prolyl oligopeptidase from Microbulbifer arenaceous provide insights into catalytic and regulatory mechanisms.
    Huang P; Lv A; Yan Q; Jiang Z; Yang S
    Acta Crystallogr D Struct Biol; 2022 Jun; 78(Pt 6):735-751. PubMed ID: 35647921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the allosteric mechanisms of prolyl endopeptidases for celiac disease therapy: Insights from molecular dynamics simulations.
    Wang Y; Xing S; Zhao X; Chen X; Zhan CG
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129313. PubMed ID: 38216012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.
    Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F
    Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.
    Shan L; Marti T; Sollid LM; Gray GM; Khosla C
    Biochem J; 2004 Oct; 383(Pt 2):311-8. PubMed ID: 15245330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Analysis of the Domain Architecture and Substrate-Gating Mechanism of Prolyl Oligopeptidases from Shewanella woodyi and Identification of Probable Lead Molecules.
    Patil P; Skariyachan S; Mutt E; Kaushik S
    Interdiscip Sci; 2016 Sep; 8(3):284-93. PubMed ID: 26298583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract.
    Fuhrmann G; Leroux JC
    Proc Natl Acad Sci U S A; 2011 May; 108(22):9032-7. PubMed ID: 21576491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.
    Tack GJ; van de Water JM; Bruins MJ; Kooy-Winkelaar EM; van Bergen J; Bonnet P; Vreugdenhil AC; Korponay-Szabo I; Edens L; von Blomberg BM; Schreurs MW; Mulder CJ; Koning F
    World J Gastroenterol; 2013 Sep; 19(35):5837-47. PubMed ID: 24124328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
    Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
    PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids as modulators of enzyme activity and stability.
    Robic S; Linscott KB; Aseem M; Humphreys EA; McCartha SR
    Protein J; 2011 Dec; 30(8):539-45. PubMed ID: 21965022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and crystal structure of prolyl endopeptidase from abalone (Haliotis discus hannai).
    Li WY; Li Y; Chen YL; Hu JJ; Mengist HM; Liu GM; Jin T; Cao MJ
    Food Chem; 2020 Dec; 333():127452. PubMed ID: 32673951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prolyl oligopeptidase family.
    Polgár L
    Cell Mol Life Sci; 2002 Feb; 59(2):349-62. PubMed ID: 11915948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Energy Optimization Strategy Based on the Perfect Conformation of Prolyl Endopeptidase for Improving Catalytic Efficiency.
    Li X; Cong Y; Ma M; You ZN; Gao B; Zhang JZH; Zhang L
    J Agric Food Chem; 2020 May; 68(18):5129-5137. PubMed ID: 32297517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein engineering of improved prolyl endopeptidases for celiac sprue therapy.
    Ehren J; Govindarajan S; Morón B; Minshull J; Khosla C
    Protein Eng Des Sel; 2008 Dec; 21(12):699-707. PubMed ID: 18836204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure, function and biological relevance of prolyl oligopeptidase.
    Szeltner Z; Polgár L
    Curr Protein Pept Sci; 2008 Feb; 9(1):96-107. PubMed ID: 18336325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.